Physician profile
Kyle Patrick Green
NPI 1194246041
$2,906.33
in general payments reported to CMS, 2019-2025
14 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $409 · 2022: $986 · 2023: $711 · 2024: $634 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,511.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $813.55 | 2022-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Getinge USA Sales, LLC | $559.01 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Abiomed | $352.73 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $282.00 | 2021-2024 | Mitris Resilia Mitral Valve |
| Zimmer Biomet Holdings, INC. | $271.76 | 2022 | |
| Baxter Healthcare | $197.04 | 2023-2024 | Perclot |
| Davol INC. | $146.45 | 2021 | |
| Intuitive Surgical, INC. | $100.00 | 2022 | |
| Smith+Nephew, INC. | $77.29 | 2023 | Renasys Go V2 Home, Pico |
| Ethicon US, LLC | $28.71 | 2024 | Evarrest, Vistaseal |
| Merck Sharp & Dohme LLC | $24.35 | 2024 | Bridion |
| Sight Sciences, INC. | $22.85 | 2021 | |
| Stryker Corporation | $16.43 | 2022 | |
| Empire Medical, INC | $14.16 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.